Intervention Protocol

You have free access to this content

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable)

  1. Nick P Rowell*,
  2. Timothy Sevitt

Editorial Group: Cochrane Lung Cancer Group

Published Online: 28 FEB 2013

Assessed as up-to-date: 21 JAN 2013

DOI: 10.1002/14651858.CD010417


How to Cite

Rowell NP, Sevitt T. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD010417. DOI: 10.1002/14651858.CD010417.

Author Information

  1. Maidstone Hospital, Kent Oncology Centre, Maidstone, Kent, UK

*Nick P Rowell, Kent Oncology Centre, Maidstone Hospital, Hermitage Lane, Maidstone, Kent, ME16 9QQ, UK. nrowell@nhs.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 28 FEB 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The main objective of this review is to summarise evidence of treatment effectiveness and associated morbidity with the purpose of assisting those involved in making treatment decisions. This update will build on the previous version (Rowell 2001a) but additionally will explore the relationship between the quality of evidence included in the review and reported outcomes. The aim of subgroup analysis will be to determine whether there are patient subgroups for whom radiotherapy may result in a better or worse outcome (in absolute terms) or for whom there may be an unacceptable degree of treatment morbidity.

This update also differs from the previous version in including patients treated with stereotactic radiotherapy, in redefining radical radiotherapy as a dose of 50Gy or more (previously 40Gy) and in not including patients with T3N0 tumours (stage IIB; UICC 2002) which in some situations would now be treated with chemoradiotherapy (NCCN 2012).

Endobronchial brachytherapy or the use of sequential or concurrent chemotherapy remain outside the scope of this review.